Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification

被引:53
|
作者
Bai, Yanhua [1 ]
Kakudo, Kennichi [2 ,3 ,4 ]
Jung, Chan Kwon [5 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Pathol, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[2] Izumi City Gen Hosp, Dept Pathol, Izumi, Japan
[3] Izumi City Gen Hosp, Thyroid Dis Ctr, Izumi, Japan
[4] Wakayama Med Univ, Dept Human Pathol, Grad Sch Med, Wakayama, Japan
[5] Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Thyroid neoplasms; Classification; Diagnosis; Prognosis; Mutation; Clinical decision-making; DIFFUSE SCLEROSING VARIANT; ENCAPSULATED FOLLICULAR VARIANT; POORLY DIFFERENTIATED CARCINOMA; COLUMNAR CELL VARIANT; HIGH-RISK GROUP; PROMINENT HOBNAIL FEATURES; ANALOG SECRETORY CARCINOMA; NUCLEAR FEATURES; TALL-CELL; MOLECULAR-FEATURES;
D O I
10.3803/EnM.2020.807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advances in medical sciences and evidence-based medicine have led to momentous changes in classification and management of thyroid neoplasms. Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers. The new 2017 World Health Organization (WHO) classification of thyroid neoplasms updated the diagnostic criteria and molecular and genetic characteristics reflecting the biology and behavior of the tumors, and newly introduced the category of borderline malignancy or uncertain malignant potential. Some neoplasms were subclassified, renamed, or redefined as a specific entity. This review introduces changes in the fourth edition WHO classification of thyroid tumors and updates the contemporary diagnosis and classification of thyroid tumors. We also discuss several challenges with the proposal of new diagnostic entities, since they have unique histopathologic and molecular features and clinical relevance.
引用
收藏
页码:696 / 715
页数:20
相关论文
共 50 条
  • [21] World Health Organization 2016 Classification of Central Nervous System Tumors
    Diamandis, Phedias
    Aldape, Kenneth
    NEUROLOGIC CLINICS, 2018, 36 (03) : 439 - +
  • [22] Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors
    A. Faggiano
    G. Mansueto
    P. Ferolla
    F. Milone
    M. L. Basso de del Caro
    G. Lombardi
    A. Colao
    G. De Rosa
    Journal of Endocrinological Investigation, 2008, 31 : 216 - 223
  • [23] The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
    Khoury, Joseph D.
    Solary, Eric
    Abla, Oussama
    Akkari, Yassmine
    Alaggio, Rita
    Apperley, Jane F.
    Bejar, Rafael
    Berti, Emilio
    Busque, Lambert
    Chan, John K. C.
    Chen, Weina
    Chen, Xueyan
    Chng, Wee-Joo
    Choi, John K.
    Colmenero, Isabel
    Coupland, Sarah E.
    Cross, Nicholas C. P.
    De Jong, Daphne
    Elghetany, M. Tarek
    Takahashi, Emiko
    Emile, Jean-Francois
    Ferry, Judith
    Fogelstrand, Linda
    Fontenay, Michaela
    Germing, Ulrich
    Gujral, Sumeet
    Haferlach, Torsten
    Harrison, Claire
    Hodge, Jennelle C.
    Hu, Shimin
    Jansen, Joop H.
    Kanagal-Shamanna, Rashmi
    Kantarjian, Hagop M.
    Kratz, Christian P.
    Li, Xiao-Qiu
    Lim, Megan S.
    Loeb, Keith
    Loghavi, Sanam
    Marcogliese, Andrea
    Meshinchi, Soheil
    Michaels, Phillip
    Naresh, Kikkeri N.
    Natkunam, Yasodha
    Nejati, Reza
    Ott, German
    Padron, Eric
    Patel, Keyur P.
    Patkar, Nikhil
    Picarsic, Jennifer
    Platzbecker, Uwe
    LEUKEMIA, 2022, 36 (07) : 1703 - 1719
  • [24] World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution
    Min Yang
    Lin Zeng
    Neng-wen Ke
    Chun-lu Tan
    Bo-le Tian
    Xu-bao Liu
    Bo Xiang
    Yi Zhang
    BMC Cancer, 20
  • [25] Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
    Loghavi, Sanam
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph D.
    Medeiros, L. Jeffrey
    Naresh, Kikkeri N.
    Nejati, Reza
    Patnaik, Mrinal M.
    MODERN PATHOLOGY, 2024, 37 (02)
  • [26] World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution
    Yang, Min
    Zeng, Lin
    Ke, Neng-wen
    Tan, Chun-lu
    Tian, Bo-le
    Liu, Xu-bao
    Xiang, Bo
    Zhang, Yi
    BMC CANCER, 2020, 20 (01)
  • [27] Categorization of allergic disorders in the new World Health Organization International Classification of Diseases
    Tanno, Luciana Kase
    Calderon, Moises A.
    Goldberg, Bruce J.
    Akdis, Cezmi A.
    Papadopoulos, Nikolaos G.
    Demoly, Pascal
    CLINICAL AND TRANSLATIONAL ALLERGY, 2014, 4
  • [28] Overview of the 2022 WHO Classification of Thyroid Neoplasms
    Baloch, Zubair W.
    Asa, Sylvia L.
    Barletta, Justine A.
    Ghossein, Ronald A.
    Juhlin, C. Christofer
    Jung, Chan Kwon
    LiVolsi, Virginia A.
    Papotti, Mauro G.
    Sobrinho-Simoes, Manuel
    Tallini, Giovanni
    Mete, Ozgur
    ENDOCRINE PATHOLOGY, 2022, 33 (01) : 27 - 63
  • [29] Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms
    Choi, Sarah M.
    O'Malley, Dennis P.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 37 : 67 - 74
  • [30] Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder
    Yorukoglu, K
    Tuna, B
    Dikicioglu, E
    Duzcan, E
    Isisag, A
    Sen, S
    Mungan, U
    Kirkali, Z
    VIRCHOWS ARCHIV, 2003, 443 (06) : 734 - 740